A drug and ATP binding site in type 1 ryanodine receptor
Structure, 2022•cell.com
The ryanodine receptor (RyR)/calcium release channel on the sarcoplasmic reticulum (SR)
is required for excitation-contraction coupling in skeletal and cardiac muscle. Inherited
mutations and stress-induced post-translational modifications result in an SR Ca 2+ leak that
causes skeletal myopathies, heart failure, and exercise-induced sudden death. A class of
therapeutics known as Rycals prevent the RyR-mediated leak, are effective in preventing
disease progression and restoring function in animal models, and are in clinical trials for …
is required for excitation-contraction coupling in skeletal and cardiac muscle. Inherited
mutations and stress-induced post-translational modifications result in an SR Ca 2+ leak that
causes skeletal myopathies, heart failure, and exercise-induced sudden death. A class of
therapeutics known as Rycals prevent the RyR-mediated leak, are effective in preventing
disease progression and restoring function in animal models, and are in clinical trials for …
Summary
The ryanodine receptor (RyR)/calcium release channel on the sarcoplasmic reticulum (SR) is required for excitation-contraction coupling in skeletal and cardiac muscle. Inherited mutations and stress-induced post-translational modifications result in an SR Ca2+ leak that causes skeletal myopathies, heart failure, and exercise-induced sudden death. A class of therapeutics known as Rycals prevent the RyR-mediated leak, are effective in preventing disease progression and restoring function in animal models, and are in clinical trials for patients with muscle and heart disorders. Using cryogenic-electron microscopy, we present a model of RyR1 with a 2.45-Å resolution before local refinement, revealing a binding site in the RY1&2 domain (3.10 Å local resolution), where the Rycal ARM210 binds cooperatively with ATP and stabilizes the closed state of RyR1.
cell.com
